Steris | STE - Trade Debtors


Steris reported $1.09B in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
3M USD 3.75B 221M Mar/2026
Accuray USD 91.79M 7.07M Sep/2024
Avanos Medical USD 103M 800K Mar/2026
Baxter International USD 1.7B 310M Mar/2026
Becton, Dickinson and Co. USD 2.2B 303M Mar/2026
Boston Scientific USD 2.93B 98M Dec/2025
CONMED USD 247.83M 22.89M Dec/2025
Cooper Companies USD 809.2M 2.1M Mar/2026
Dexcom USD 1.09B 182.1M Mar/2026
Ecolab USD 3.28B 30.8M Mar/2026
Edwards Lifesciences USD 912.1M 19.3M Dec/2025
Fortive USD 647M 36.6M Mar/2026
Getinge SEK 8.61B 1.78B Dec/2024
Globus Medical USD 735.44M 8.23M Mar/2026
Haemonetics USD 195.71M 11.36M Dec/2025
Idexx Laboratories USD 697.21M 144.83M Mar/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 544.7M 27.8M Mar/2026
Integra LifeSciences USD 264.41M 14.44M Mar/2026
Intuitive Surgical USD 1.6B 68.3M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Masimo USD 288.9M 103M Mar/2026
Olympus JPY 334.31B 55.98B Mar/2026
Orthofix International USD 135.75M 4.94M Dec/2025
Owens Minor USD 95.91M 106.82M Dec/2025
ResMed USD 998.84M 13.2M Mar/2026
Steris USD 1.09B 102.2M Mar/2026
Stryker USD 3.57B 468M Mar/2026
Tandem Diabetes Care USD 165.49M 39.55M Dec/2025
Teleflex USD 365.53M 19.94M Mar/2026
Thermo Fisher Scientific USD 9.2B 304M Mar/2026
Zimmer Biomet Holdings USD 1.73B 24.2M Mar/2026